Lung Cancer Informational Study (LCIS)

Completed · Not applicable

Conditions studied: Cancer, Enhanced Care, Decision-Making, Advance Lung Cancer, Stage III Lung Cancer, Stage IV Lung Cancer

In brief

The purpose of this study is to evaluate a new program to help the patient and the caregiver make decisions about treatment for lung cancer. We need to know if a new information program is helpful to patients. The way that we will do this is by comparing it with the usual information program that we now provide. Patient are asked to make difficult decisions about their treatments. These decisions may include when to change treatments or when to stop treatment altogether. Most patients ask a family member or close friend to help them with these difficult decisions. A "caregiver" is someone they can count on to give support (either emotional or physical) over a period of time. The doctors and nurses will also help patients and their caregiver to make these decisions. They will tell them the risks with each treatment, the success with each treatment, and how much time there is for making each decision.

Key facts

Study ID

NCT00579215

Run by

Memorial Sloan Kettering Cancer Center

People needed

8

Starts

2006-11-01

Expected to finish

2009-03-01

Last updated by the study team

2009-03-18

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pathologically or cytologically determined non-small cell lung cancer
• Stage IIIA, IIIB or IV extent
• No prior chemotherapy unless used in adjuvant therapy, completed more than two years ago, and no sign of any other malignancy active at this time
• Lung cancer-directed treatment with a standard or investigative chemotherapy regimen at entry
• Patients with brain metastasis are acceptable provided they are at least 3 weeks from completion of radiation therapy for brain metastasis, have stable and acceptable neurological status, and meet all other eligibility criteria. For patients undergoing gamma knife procedure, cognitive ability is the judgment call of the oncologist and study nurse as to whether comprehension is not a problem.

You may not qualify if…

• Performance status of KPS 60-100% or ECOG 0-2;
• No age limit
• Life expectancy greater than three months
• A caregiver (any family member or concerned other who consistently provides emotional and/or physical support) available to also participate
• Patient and caregiver are able to understand English (ability to repeat back in their own words)

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• University of Virginia- School of Nursing — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.